Dialysis provider DaVita Inc. reported net income for the third quarter of 2012 rose almost 7% to $144.7 million, or $1.50 per share compared to $135.4, or $1.42 per share, in the same quarter last year.
Operating results include an additional $5.4 million of after-tax debt expense, or $0.06 per share, resulting from the proposed amendments under DaVita's senior secured credit facilities as well as issuing the new senior notes in advance of the acquisition of HealthCare Partners.
Total dialysis treatments in DaVita's 2012 third quarter
Total U.S. treatments for the third quarter of 2012 were 5,550,645, or 71,162 treatments per day, representing a per day increase of 12.3% over the third quarter of 2011. Non-acquired treatment growth, 4.4% over the prior year's third quarter.